Company · CIK 0001590560 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
uniQure N.V. · QURE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2017 MForm 4 → | Jun 28, 5:05 pm EDT | Harald PetryChief Scientific Officer | 65,930 | $3.44 | $226,700 | 7,700 | — | plan? late |
| Jun 5, 2017 AForm 4 → | Jun 7, 4:34 pm EDT | Steven ZelenkofskeChief Medical Officer | 175,000 | — | — | 175,000 | — | plan? |
| Mar 21, 2017 SForm 4 → | Jun 8, 4:33 pm EDT | Harald PetryChief Scientific Officer | 25,422 | $6.03 | $153,290 | 0 | −100% | plan? late |
| Mar 21, 2017 MForm 4 → | Jun 8, 4:33 pm EDT | Harald PetryChief Scientific Officer | 25,422 | $3.30 | $83,799 | 25,422 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 MForm 4 → | Jul 7, 4:47 pm EDT | Matthew C KapustaCEO, Managing Director, Director | 21,082 | — | — | 0 | — | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 4:59 pm EDT | Walid Abi-SaabChief Medical Officer | 10,000 | — | — | 50,500 | — | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 4:54 pm EDT | Jack KayeDirector | 21,167 | — | — | 0 | — | 10b5-1 |
| Jun 24, 2026 MForm 4 → | Jun 26, 5:15 pm EDT | Matthew C KapustaCEO, Managing Director, Director | 32,844 | — | — | 45,862 | — | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 22, 8:31 am EDT | Matthew C KapustaCEO, Managing Director, Director | 67,237 | — | — | 78,706 | — | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 22, 8:05 am EDT | Madhavan BalachandranDirector | 11,685 | — | — | 0 | — | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 22, 7:54 am EDT | Jack KayeDirector | 5,295 | — | — | 0 | — | 10b5-1 |
| Jun 15, 2026 MForm 4 → | Jun 17, 5:02 pm EDT | Madhavan BalachandranDirector | 10,000 | — | — | 0 | — | 10b5-1 |
| Jun 10, 2026 AForm 4 → | Jun 12, 6:13 pm EDT | David D. MeekDirector | 13,980 | — | — | 13,980 | — | |
| Jun 10, 2026 AMForm 4 → | Jun 12, 6:04 pm EDT | Robert GutDirector | 16,625 | — | — | 13,980 | — | 10b5-1 |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:45 pm EDT | Jeremy P. SpringhornDirector | 13,980 | — | — | 13,980 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:38 pm EDT | Leonard E PostDirector | 13,980 | — | — | 13,980 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:30 pm EDT | Jack KayeDirector | 13,980 | — | — | 13,980 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:15 pm EDT | Rachelle Suzanne JacquesDirector | 13,980 | — | — | 13,980 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:08 pm EDT | Madhavan BalachandranDirector | 13,980 | — | — | 13,980 | — | |
| Jun 3, 2026 MForm 4 → | Jun 5, 4:43 pm EDT | Jack KayeDirector | 2,645 | — | — | 0 | — | 10b5-1 |
| Feb 15, 2019 MForm 4 → | Feb 20, 2:18 pm EST | Alexander Edward Kuta IIISVP, Regulatory Affairs | 20,000 | — | — | 130,000 | — | |
| Jan 25, 2019 AForm 4 → | Jan 31, 5:13 pm EST | Jack KayeDirector | 5,295 | — | — | 5,295 | — | late |
| Jan 25, 2019 AForm 4 → | Jan 29, 8:47 pm EST | Sander van DeventerChief Scientific Officer | 18,325 | — | — | 18,325 | — | |
| Jan 25, 2019 AForm 4 → | Jan 29, 8:43 pm EST | Jeremy P. SpringhornDirector | 5,295 | — | — | 5,295 | — | |
| Jan 25, 2019 AForm 4 → | Jan 29, 8:37 pm EST | Paula SoteropoulosDirector | 5,295 | — | — | 5,295 | — | |
| Jan 25, 2019 AForm 4 → | Jan 29, 8:32 pm EST | David SchafferDirector | 5,295 | — | — | 5,295 | — | |
| Jan 25, 2019 AForm 4 → | Jan 29, 8:01 pm EST | David D. MeekDirector | 5,295 | — | — | 5,295 | — | |
| Jan 25, 2019 AForm 4 → | Jan 29, 7:54 pm EST | Scott T. McMillanChief Operating Officer | 28,934 | — | — | 28,934 | — | |
| Jan 25, 2019 AForm 4 → | Jan 29, 7:45 pm EST | Alexander Edward Kuta IIISVP, Regulatory Affairs | 19,883 | — | — | 19,883 | — | |
| Jan 25, 2019 AForm 4 → | Jan 29, 7:39 pm EST | Christian KlemtChief Accounting Officer | 18,651 | — | — | 18,651 | — | |
| Jan 25, 2019 AForm 4 → | Jan 29, 7:07 pm EST | Matthew C KapustaCEO, CFO, Managing Director, Director | 83,362 | — | — | 83,362 | — | |
| Jan 25, 2019 AForm 4 → | Jan 29, 6:58 pm EST | Robert GutChief Medical Officer, Director | 16,877 | — | — | 16,877 | — | |
| Jan 25, 2019 AForm 4 → | Jan 29, 6:53 pm EST | Madhavan BalachandranDirector | 5,295 | — | — | 5,295 | — | |
| Jan 25, 2019 AForm 4 → | Jan 29, 6:48 pm EST | Philip Astley-SparkeDirector | 5,295 | — | — | 5,295 | — | |
| Sep 18, 2018 AForm 4 → | Sep 25, 1:56 pm EDT | Robert GutChief Medical Officer | 70,000 | — | — | 70,000 | — | late |
| Jun 14, 2018 AForm 4 → | Jun 18, 10:38 am EDT | Robert GutDirector | 10,000 | — | — | 10,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 18, 10:31 am EDT | David D. MeekDirector | 10,000 | — | — | 10,000 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 1:11 pm EST | Sander van DeventerChief Scientific Officer | 20,788 | — | — | 20,788 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 12:02 pm EST | Steven ZelenkofskeChief Medical Officer | 22,364 | — | — | 22,364 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 11:51 am EST | Jeremy P. SpringhornDirector | 6,390 | — | — | 6,390 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 11:47 am EST | Scott T. McMillanChief Operating Officer | 13,419 | — | — | 13,419 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 11:43 am EST | Christian KlemtChief Accounting Officer | 22,620 | — | — | 22,620 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 11:39 am EST | Matthew C KapustaCEO, CFO, Managing Director, Director | 83,663 | — | — | 83,663 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 11:35 am EST | Jonathan GarenChief Business Officer | 22,364 | — | — | 22,364 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 11:31 am EST | Paul E FirutaChief Commercial Officer | 22,843 | — | — | 22,843 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 11:26 am EST | Maria E CantorSVP, Investor Rel. & Comm. | 19,169 | — | — | 19,169 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 11:20 am EST | Madhavan BalachandranDirector | 6,390 | — | — | 6,390 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 10:46 am EST | Paula SoteropoulosDirector | 6,390 | — | — | 6,390 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 10:42 am EST | David SchafferDirector | 6,390 | — | — | 6,390 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 10:37 am EST | Alexander Edward Kuta IIISVP, Regulatory Affairs | 23,962 | — | — | 23,962 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 10:32 am EST | Jack KayeDirector | 6,390 | — | — | 6,390 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 10:21 am EST | Philip Astley-SparkeDirector | 6,390 | — | — | 6,390 | — | |
| Sep 20, 2017 AForm 4 → | Sep 26, 5:15 pm EDT | Jeremy P. SpringhornDirector | 10,000 | — | — | 10,000 | — | late |
| Sep 20, 2017 AForm 4 → | Sep 22, 4:35 pm EDT | Madhavan BalachandranDirector | 10,000 | — | — | 10,000 | — | |
| Sep 20, 2017 AForm 4 → | Sep 22, 4:34 pm EDT | Sander van DeventerChief Scientific Officer | 150,000 | — | — | 150,000 | — | |
| Sep 20, 2017 AForm 4 → | Sep 22, 4:32 pm EDT | Scott T. McMillanChief Operating Officer | 150,000 | — | — | 150,000 | — | |
| Jun 28, 2017 MForm 4 → | Jun 29, 5:05 pm EDT | Harald PetryChief Scientific Officer | 49,300 | — | — | 0 | — | |
| Jun 22, 2017 MForm 4 → | Jun 28, 5:05 pm EDT | Harald PetryChief Scientific Officer | 65,930 | — | — | 49,300 | — | late |
| May 9, 2017 AForm 4 → | May 10, 9:59 am EDT | Matthew C KapustaCEO, CFO, Managing Director, Director | 350,000 | — | — | 350,000 | — | |
| Mar 21, 2017 MForm 4 → | Jun 8, 4:33 pm EDT | Harald PetryChief Scientific Officer | 25,422 | — | — | 115,230 | — | late |
| Jan 27, 2017 AForm 4 → | Mar 3, 11:25 am EST | Matthew C KapustaCEO, CFO, Managing Director, Director | 162,500 | — | — | 247,124 | — | late |
| Jan 27, 2017 AForm 4/A → | Feb 21, 5:08 pm EST | Harald PetryChief Scientific Officer | 86,500 | — | — | 43,500 | — | |
| Jan 27, 2017 AForm 4/A → | Feb 21, 5:07 pm EST | Christian MeyerChief Medical Officer | 86,500 | — | — | 43,500 | — | |
| Jan 27, 2017 AForm 4/A → | Feb 21, 5:06 pm EST | Maiken Keson-BrookesGeneral Counsel | 86,500 | — | — | 43,500 | — | |
| Jan 27, 2017 AForm 4/A → | Feb 21, 5:05 pm EST | Jonathan GarenChief Business Officer | 86,500 | — | — | 43,500 | — | |
| Jan 27, 2017 AForm 4/A → | Feb 21, 5:04 pm EST | Paul E FirutaChief Commercial Officer | 86,500 | — | — | 43,500 | — | |
| Jan 27, 2017 AForm 4/A → | Feb 21, 5:03 pm EST | Maria E CantorSVP, Investor Relations | 86,500 | — | — | 43,500 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 3:28 pm EST | Maiken Keson-BrookesGeneral Counsel | 86,500 | — | — | 43,250 | — | amended |
| Jan 27, 2017 AForm 4 → | Jan 31, 3:26 pm EST | Jonathan GarenChief Business Officer | 86,500 | — | — | 43,250 | — | amended |
| Jan 27, 2017 AForm 4 → | Jan 31, 3:25 pm EST | Maria E CantorSVP, Investor Relations | 86,500 | — | — | 43,250 | — | amended |
| Jan 27, 2017 AForm 4 → | Jan 31, 3:23 pm EST | Paul E FirutaChief Commercial Officer | 86,500 | — | — | 43,250 | — | amended |
| Jan 27, 2017 AForm 4 → | Jan 31, 3:22 pm EST | Harald PetryChief Scientific Officer | 86,500 | — | — | 55,250 | — | amended |
| Jan 27, 2017 AForm 4 → | Jan 31, 3:20 pm EST | Christian MeyerChief Medical Officer | 86,500 | — | — | 55,250 | — | amended |
| Jan 27, 2017 AForm 4 → | Jan 31, 3:19 pm EST | Matthew C KapustaCEO, CFO, Managing Director, Director | 162,500 | — | — | 247,124 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 3:17 pm EST | Sander van DeventerDirector | 22,000 | — | — | 16,000 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 3:03 pm EST | Paula SoteropoulosDirector | 22,000 | — | — | 16,000 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 3:02 pm EST | David SchafferDirector | 22,000 | — | — | 16,000 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 3:00 pm EST | William LewisDirector | 22,000 | — | — | 16,000 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 2:57 pm EST | Jack KayeDirector | 22,000 | — | — | 11,000 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 2:56 pm EST | Philip Astley-SparkeDirector | 50,000 | — | — | 30,000 | — |